Tumorigenic Th17 cells in oncogenic Kras-driven and inflammation-accelerated lung cancer

OncoImmunology

Volumn 4, Issue 1, 2015, Pages 955704-

  Chang, Seon Hee ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

GR1^{+< sup> CD11b+< sup> cells; Kras; lung adenocarcinoma; Th17}

Indexed keywords

CD11B ANTIGEN; EARLY GROWTH RESPONSE FACTOR 1; INTERLEUKIN 17; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3;

ANGIOGENESIS; ARTICLE; BONE MARROW CELL; CARCINOGENESIS; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL PROLIFERATION; GENE MUTATION; INFLAMMATION; LUNG ADENOCARCINOMA; LUNG ALVEOLUS EPITHELIUM; NONHUMAN; ONCOGENE K RAS; REGULATORY T LYMPHOCYTE; STROMA CELL; SUPPRESSOR CELL; TH1 CELL; TH17 CELL; TUMOR IMMUNITY;

EID: 84938702936     PISSN: 21624011     EISSN: 2162402X     Source Type: Journal    
DOI: 10.4161/21624011.2014.955704     Document Type: Article

References (9)

1. G.J.Martinez, R.I.Nurieva, X.O.Yang, C.Dong. Regulation and function of proinflammatory TH17 cells. Ann New York Acad Sci 2008; 1143:188-211; PMID:19076351; dx.doi.org/10.1196/annals.1443.021
2. S.H.Chang, C.Dong. Signaling of interleukin-17 family cytokines in immunity and inflammation. Cell Signal 2011; 23:1069-75; PMID:21130872; dx.doi.org/10.1016/j.cellsig.2010.11.022
3. P.Miossec, J.K.Kolls. Targeting IL-17 and TH17 cells in chronic inflammation. Nat Rev Drug Dis 2012; 11:763-76; PMID:23023676; dx.doi.org/10.1038/nrd3794
4. W.P.Zou, N.P.Restifo. T(H)17 cells in tumour immunity and immunotherapy (vol 10, pg 248, 2010). Nat Rev Immunol 2011; 11:565; PMID:20336152; dx.doi.org/10.1038/nri3029
5. S.H.Chang, S.G.Mirabolfathinejad, H.Katta, A.M.Cumpian, L.Gong, M.S.Caetano, S.J.Moghaddam, C.Dong. T helper 17 cells play a critical pathogenic role in lung cancer. Proc Nat Acad Sci U S A 2014; 111:5664-9; PMID:24706787; dx.doi.org/10.1073/pnas.1319051111
6. S.J.Moghaddam, H.Li, S.N.Cho, M.K.Dishop, I.I.Wistuba,, L.Ji, J.M.Kurie, B.F.Dickey, F.J.Demayo. Promotion of lung carcinogenesis by chronic obstructive pulmonary disease-like airway inflammation in a K-ras-induced mouse model. Am J Respir Cell Mol Biol 2009; 40:443-53; PMID:18927348; dx.doi.org/10.1165/rcmb.2008-0198OC
7. L.Wang, T.Yi, M.Kortylewski, D.M.Pardoll, D.Zeng, H.Yu. IL-17 can promote tumor growth through an IL-6-Stat3 signaling pathway. J Exp Med 2009; 206:1457-64; PMID:19564351; dx.doi.org/10.1084/jem.20090207
8. D.I.Gabrilovich, S.Ostrand-Rosenberg, V.Bronte. Coordinated regulation of myeloid cells by tumours. Nat Rev Immunol 2012; 12:253-68; PMID:22437938; dx.doi.org/10.1038/nri3175
9. H.Ji, A.M.Houghton, T.J.Mariani, S.Perera, C.B.Kim, R.Padera, G.Tonon, K.McNamara, L.A.Marconcini, A.Hezel, K-ras activation generates an inflammatory response in lung tumors. Oncogene 2006; 25:2105-12; PMID:16288213; dx.doi.org/10.1038/sj.onc.1209237